Document 0795 DOCN M9590795 TI Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells. DT 9509 AU Garnier L; Ravallec M; Blanchard P; Chaabihi H; Bossy JP; Devauchelle G; Jestin A; Cerutti M; Laboratorie de Pathologie Comparee, Centre National de la; Recherche Scientifique UA 1184, France. SO J Virol. 1995 Jul;69(7):4060-8. Unique Identifier : AIDSLINE MED/95287455 AB The human immunodeficiency virus type 1 (HIV-1) Pr55gag precursors were previously shown to assemble and bud efficiently as noninfectious virus-like particles (VLPs) when expressed in baculovirus-infected insect cells. In this study, we examined the abilities of foreign antigens to be incorporated on the outer surface of HIV-1 Gag particles. We have used a dual recombinant baculovirus, expressing the HIV-1 Gag gene and gD gene under the control of the P10 and polyhedrin promoters, respectively, to obtain hybrid VLPs. Transmission electron microscopy of insect cells infected with the dual recombinant revealed very large aggregates of particles budding from the cell membrane. The release of VLPs into the culture medium was clearly different for a recombinant baculovirus producing solely HIV-1 Gag, for which particles were uniformly distributed all around the cell surface. Biochemical analysis of hybrid particles indicated that glycoprotein gD was packaged into HIV-1 Gag VLPs. Moreover, the carboxy-terminal p6 region of Gag polyprotein and the glycoprotein gD intracytoplasmic domain were not required for gD incorporation. The experiments described here clearly demonstrate that glycoprotein gD can be packaged with HIV-1 Gag particles and released from insect cells. DE Animal Baculoviridae/GENETICS Cells, Cultured Gene Products, gag/*METABOLISM HIV-1/*METABOLISM Recombinant Proteins/METABOLISM Spodoptera Viral Envelope Proteins/*METABOLISM JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).